Friday, August 2, 2019

Recent Trends in Oncology


FDA approved pembrolizumab monotherapy for patients with recurrent locally advanced or metastatic PD-L1 positive esophageal squamous cell carcinoma. Explore more about cancer here: http://bit.ly/2K4sRl4
#CancerConferences


No comments:

Post a Comment